He is interested in the development of patientfriendly and efficacious nanotechnologies for drug delivery. The key in this process is to address the unmet need in the drug administration with innovative strategies that can be quickly translated from bench to bedside. Currently, his laboratory is interested in developing nanotechnologies for the targeted drug delivery in the most common diseases like cancer and scar formation.